Black Rock Inc. Lexicon Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,890,153 shares of LXRX stock, worth $7.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,890,153

Previous 7,693,277 28.56%

Holding current value

$7.32 Million

Previous $18.5 Million 10.01%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.54 - $2.28 $3.38 Million - $5.01 Million	2,196,876 Added 28.56%	9,890,153 $16.6 Million
Q1 2024 May 10, 2024	BUY	$1.3 - $3.58 $894,561 - $2.46 Million	688,124 Added 9.82%	7,693,277 $18.5 Million
Q4 2023 Feb 13, 2024	BUY	$1.0 - $1.53 $350,187 - $535,786	350,187 Added 5.26%	7,005,153 $10.7 Million
Q3 2023 Nov 13, 2023	BUY	$1.06 - $2.33 $292,326 - $642,567	275,780 Added 4.32%	6,654,966 $7.25 Million
Q2 2023 Aug 11, 2023	BUY	$2.15 - $3.49 $1.55 Million - $2.52 Million	722,259 Added 12.77%	6,379,186 $14.6 Million
Q1 2023 May 12, 2023	SELL	$1.99 - $2.68 $389,160 - $524,095	-195,558 Reduced 3.34%	5,656,927 $13.7 Million
Q4 2022 Feb 13, 2023	BUY	$1.8 - $2.56 $166,473 - $236,761	92,485 Added 1.61%	5,852,485 $11.2 Million
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $2.41 Million - $4.25 Million	1,240,171 Added 27.44%	5,760,000 $13.8 Million
Q2 2022 Aug 12, 2022	BUY	$1.31 - $2.69 $97,040 - $199,267	74,077 Added 1.67%	4,519,829 $8.41 Million
Q1 2022 May 12, 2022	SELL	$1.95 - $3.89 $199,235 - $397,449	-102,172 Reduced 2.25%	4,445,752 $9.29 Million
Q4 2021 Feb 10, 2022	SELL	$3.81 - $6.16 $391,462 - $632,915	-102,746 Reduced 2.21%	4,547,924 $17.9 Million
Q3 2021 Nov 09, 2021	BUY	$3.38 - $5.35 $12,881 - $20,388	3,811 Added 0.08%	4,650,670 $22.4 Million
Q2 2021 Aug 11, 2021	BUY	$4.12 - $5.87 $19.1 Million - $27.3 Million	4,646,859 New	4,646,859 $21.3 Million

Others Institutions Holding LXRX

# of Institutions

135

Shares Held

196M

Call Options Held

310K

Put Options Held

77.3K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $140M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account